Stavudine (d4T), sold under the brand name Zerit among others, is an antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. However, it is not a first-line treatment. It is given by mouth.Common side effects include headache, diarrhea, vomiting, rash, and peripheral nerve problems. Severe side effects include high blood lactate, pancreatitis, and an enlarged liver. It is not generally recommended in pregnancy. Stavudine is in the nucleoside analog reverse-transcriptase inhibitor (NRTI) class of medication.Stavudine was first described in 1966 and approved for use in the United States in 1994. It is available as a generic medication. Medical uses
Stavudine is used in the treatment of HIV-1 infection, but is not a cure. It is not normally recommended as initial treatment. Stavudine can also reduce the risk of developing HIV-1 infection after coming into contact with the virus either at work (e.g., needlestick) or through exposure to infected blood or other bodily fluids. It is always used in combination with other HIV medications for the better control of the infection and a reduction in HIV complications.The World Health Organization (WHO) recommends stavudine to be phased out to due to its high toxicity levels. If the drug must be used, it is recommended to use low dosages to reduce the occurrence of side effects; however, a 2015 Cochrane review found no clear advantage between high and low dosage regimens.
See also
References
Further reading
Hyatt, Keith J (February 2010). "Irlen Tinted Lenses and Overlay" (PDF). MUSEC Briefings. Macquarie University Special Education Centre (22). Archived from the original (PDF) on 29 August 2017. Retrieved 22 April 2017. Wilkins, Arnold J. (2003). Reading through color: how colored filters can reduce reading difficulty, eye strain, and headaches. Chichester: John Wiley & Sons. ISBN 0-470-85116-3. OCLC 78883050.